Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 8, 2003, Pages 3562-3569

  Bourges, Jean Louis ^a,b,c   Gautier, Sandrine E ^d   Delie, Florence ^e   Bejjani, Riad A ^a,b   Jeanny, Jean Claude ^a,b   Gurny, Robert ^e   BenEzra, David ^f   Behar Cohen, Francine F ^a,b,c  

^a INSERM   (France)

^b FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF GENEVA   (Switzerland)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; NANOPARTICLE; NILE RED; POLYLACTIC ACID; RHODAMINE 6G; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL MARKERS; DRUG DELIVERY SYSTEMS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; INJECTIONS; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MICROSPHERES; OXAZINES; PIGMENT EPITHELIUM OF EYE; POLYESTERS; RATS; RATS, INBRED LEW; RETINA; RHODAMINES; TISSUE DISTRIBUTION; VITREOUS BODY;

EID: 0042844771     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-1068     Document Type: Article

References (24)

1. Grizzi I, Garreau H, Li S, Vert M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials. 1995; 16:305-311.
2. Mainil-Varlet P, Curtis R, Gogolewski S. Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular-weight polylactides. J Biomed Mater Res. 1997;36:360-380.
3. Delie F, Berton M, Allemann E, Gurny R. Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles. Int J Pharm. 2001;214:25-30.
4. Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C. Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles. Int J Pharm. 2001;212:1-9.
5. Alleman E, Leroux J, Gurny R. Polymeric nano and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Deliv Rev. 1998;34:171-183.
6. Li Y, Pei Y, Zhang X, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 2001;71:203-211.
7. Cohen H, Levy RJ, Gao J, et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 2000; 7:1896-1905.
8. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001; 53:283-318.
9. Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47:3-19.
10. McClean S, Prosser E, Meehan E, et al. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci. 1998;6:153-163.
11. Calvo P, Sanchez A., Martinez J, et al. Polyester nanocapsules as new topical delivery systems for Cyclosporin A. Pharm Res. 1996; 13:311-315.
12. Calvo P, Vila-Jato JL, Alonso M. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules and nanoemulsions, as drug carriers. J Pharm Sci. 1996;85:530-536.
13. Calvo P, Thomas C, Alonson MJ, Vila-Jato JL, Robinson J. Study of the mechanism of interaction of poly(E-coprolactone) nanocapsules with the cornea by confocal laser scanning microscopy. Int J Pharm. 1994;103:283-291.
14. Gautier S, Grudzielski N, Goffinet G, et al. Preparation of poly(D,L-lactide) nanoparticles assisted by amphophilic poly(methyl methacrylate-co-methacrylic acid) copolymers. J Biomater Sci Polym. 2001;12:429-450.
15. Scholes PD, Coombes AGA, Illum L, Davis SS, Vert M, Davies MC. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Release. 1993;25:145-153.
16. De Jaeghere F, Allémann E., Leroux JC, et al. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res. 1999;16:859-866.
17. Djano S, Martin-Iverson MT. Does locomotor response to novelty in rats predict susceptibility to develop sensitization to cocaine and PHNO? Behav Pharmacol. 2000;11:455-470.
18. Behar-Cohen FF, BenEzra D, Einmahl S, Gurny R. Challenges of intraocular drug delivery. Eur Pharm Rev. 2001;35-39.
19. Sakurai E, Ozeki H, Kunou N, Ogura Y. Effect of particle size of polymeric nanospheres on intravitreous kinetics. Ophthalmic Res. 2001;33:31-36.
20. Kimura H, Ogura Y, Moritera T, Honda Y, Tabata Y, Ikada Y. In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release. Curr Eye Res. 1994; 13:353-360.
21. Ogura Y, Kimura H. Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium. Surv Ophthalmol. 1995;39(suppl 1):S17-S24.
22. Galgut P, Waite I, Smith R. Tissue reactions to biodegradable and non-degradable membranes placed transcutaneously in rats, observed longitudinally over a period of 4 weeks. J Oral Rehabil. 1996;23:17-21.
23. Gogolewslki S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 1993;27:1135-1148.
24. Kobayashi H, Shiraki K, Ikada Y. Toxicity test of biodegradable polymers by implantation in rabbit cornea. J Biomed Mater Res. 1992;26:1463-1476.